Sensorineural deafness with dilated cardiomyopathy: A Patient Guide
At a Glance
Sensorineural hearing loss and dilated cardiomyopathy can occur together as a shared genetic or biological pattern. Genetic testing may identify the cause, but coordinated cardiology, audiology, and genetics care is still important when results are negative or unclear.
A diagnosis that involves both your heart and your hearing can feel like navigating two separate worlds at once. However, in medicine, this combination is recognized as a cardio-auditory phenotype, a term that describes how a single underlying genetic variant or mechanism can affect these two seemingly unrelated systems [1]. Understanding this as a unified condition—rather than an exhaustive single diagnosis—is the first step toward coordinated care. This guide is designed to help you and your family understand the biology behind these symptoms and the modern medical path forward.
What this diagnosis does and does not mean
- Phenotype: The observable characteristics or symptoms (like hearing loss and a weak heart).
- Syndrome: A recognizable set of symptoms that tend to occur together.
- Gene/Variant: The specific DNA instruction that is altered. A genetic result can explain risk without predicting exactly what will happen to you.
The connection between the inner ear and the heart muscle lies in their shared biological needs. Both the cochlea (the hearing organ) and the myocardium (the heart muscle) are tissues that rely on a constant, high-volume supply of cellular energy to function correctly [2]. When a genetic mutation disrupts this energy production or affects the structural “scaffolding” of these cells, both systems can show signs of strain. This may manifest as sensorineural hearing loss, where the inner ear struggles to send clear signals to the brain, and dilated cardiomyopathy, where the heart muscle weakens and the heart’s main chamber enlarges [3][4].
Examples of genes and conditions that cause this pattern include EYA4 variants, Alström syndrome, or mitochondrial disorders [5][6]. Identifying your specific genetic driver is helpful because it serves as a roadmap for your care. While the symptoms may not appear at the same time—often with hearing loss preceding heart issues by several years—knowing the genetic cause allows your doctors to monitor your health proactively rather than simply reacting to symptoms after they appear [7]. Genetic testing can help identify a cause, but it may also be negative or inconclusive while clinical evaluation continues. A negative test for these examples does not rule out inherited disease.
Living with a cardio-auditory phenotype means working with a multidisciplinary team of specialists, including cardiologists, audiologists, and geneticists. While the condition is rare and complex, it is also the subject of significant ongoing research. Modern treatments—from advanced heart medications to hearing technologies like cochlear implants—can reduce risk and support your heart function, while helping maintain your connection to the world around you [8][9]. Outcomes vary depending on age, ejection fraction, rhythm risk, and hearing-nerve function. By staying informed and engaged with your medical team, you can manage these challenges and focus on individualized care, as your team will give you a specific prognosis.
In this guide
6 chapters
Understanding the Heart-Hearing Connection
Learn how sensorineural hearing loss and dilated cardiomyopathy may share a genetic cause, including EYA4, Alström syndrome, testing, monitoring, and team care.
Monitoring Symptoms and Recognizing Emergencies
Learn to recognize heart failure, rhythm, hearing, and stroke warning signs in sensorineural deafness with dilated cardiomyopathy, and when to seek urgent care.
The Biology of Heart and Hearing Loss
Learn how sensorineural deafness and dilated cardiomyopathy can be linked; explore genetic causes, inheritance patterns, testing, and how JLNS differs clinically.
Treatment Options and Decisions
Learn how heart and hearing treatments, including medicines, devices, and cochlear implants, help manage sensorineural deafness with dilated cardiomyopathy.
Building Your Care Team and Preparing for Your First Visit
Learn how to build a care team for sensorineural deafness with dilated cardiomyopathy and prepare records, family history, and questions for your first visit.
Long-Term Care and Monitoring
Learn how to monitor sensorineural deafness with dilated cardiomyopathy, including heart and hearing tests, family screening, risk markers, and coping support.
Common questions in this guide
Can hearing loss and a weakened heart be part of the same condition?
What can cause sensorineural deafness with dilated cardiomyopathy?
What does genetic testing tell me about this heart and hearing problem?
Which specialists should coordinate my care?
Can hearing loss happen before heart problems?
What treatments may help when both hearing and heart function are affected?
What affects the outlook for this condition?
Get notified when new evidence is published on Sensorineural deafness with dilated cardiomyopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
Genome-first approach to rare EYA4 variants and cardio-auditory phenotypes in adults.
Ahmadmehrabi S, Li B, Park J, et al.
Human genetics 2021; (140(6)):957-967 doi:10.1007/s00439-021-02263-6.
PMID: 33745059 - 2
A retrospective cohort study exploring the association between different mitochondrial diseases and hearing loss.
van Kempen CMA, Beynon AJ, Smits JJ, Janssen MCH
Molecular genetics and metabolism 2022; (135(4)):333-341 doi:10.1016/j.ymgme.2022.02.003.
PMID: 35190254 - 3
Audiometric Characteristics of a Dutch DFNA10 Family With Mid-Frequency Hearing Impairment.
van Beelen E, Oonk AM, Leijendeckers JM, et al.
Ear and hearing 2016; (37(1)):103-11 doi:10.1097/AUD.0000000000000217.
PMID: 26331839 - 4
Dilated Cardiomyopathy in Children: Early Detection and Treatment.
Mallavarapu A, Taksande A
Cureus 2022; (14(11)):e31111 doi:10.7759/cureus.31111.
PMID: 36475220 - 5
Sensorineural hearing loss and mild cardiac phenotype caused by an EYA4 mutation.
Abe S, Takeda H, Nishio SY, Usami SI
Human genome variation 2018; (5()):23 doi:10.1038/s41439-018-0023-9.
PMID: 30155266 - 6
Auditory and otologic profile of Alström syndrome: Comprehensive single center data on 38 patients.
Lindsey S, Brewer C, Stakhovskaya O, et al.
American journal of medical genetics. Part A 2017; (173(8)):2210-2218 doi:10.1002/ajmg.a.38316.
PMID: 28573831 - 7
Novel EYA4 variant in Slovak family with late onset autosomal dominant hearing loss: a case report.
Varga L, Danis D, Skopkova M, et al.
BMC medical genetics 2019; (20(1)):84 doi:10.1186/s12881-019-0806-y.
PMID: 31101089 - 8
Emerging concepts in heart failure management and treatment: focus on current guideline-directed medical therapy for heart failure with reduced ejection fraction.
Ospina González OE, Llanos Mejía DC, Kaplinsky E, et al.
Drugs in context 2023; (12()) doi:10.7573/dic.2022-6-4.
PMID: 36660017 - 9
Cochlear Implantation in Alport Syndrome: A Novel Case Series.
Moon E, Bond L, Gordon SA
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2026; (47(1)):e27-e30 doi:10.1097/MAO.0000000000004687.
PMID: 41170855
This page is for informational purposes only and does not constitute medical advice. Your cardiologist, audiologist, and genetics team should interpret your tests and tailor care to your situation.